Articles By Rob Wright, Chief Editor
The Leadership Meeting – Where Leaders Go To Learn
Rob Wright provides a high-level overview of The Leadership Meeting, a pre-JPM conference with content specifically curated for professional development of c-level life science leaders.
Can You Help With Gender Diversity In The New Year?
Despite a banner year for Life Science Leader having diversity well represented on its covers, chief editor Rob Wright admits there is more work to be done and seeks help from readers in connecting to more diverse leaders of biopharma.
J&J And Merck Detail How They Are Investing For Impact
Two Big Pharma executives explain how their organizations are investing for impact.
The 5-Step Strategy That Saved Genmab From A Dire Outlook
Jan G. J. van de Winkel, Ph.D., cofounder, president, and CEO since 2010, remembers when Genmab faced some pretty tough decisions.
Brightspot: How A Biopharma VC Makes A Difference For Orphans
Ed Torres, managing partner at Lilly Ventures, shares how he and his wife got involved in making a difference for U.S. orphans.
Want To Know What 7 Biopharma Manufacturing Execs Expect for 2020 – And Beyond?
Therapy designations and FDA approvals don’t mean much if the product can’t be manufactured at the level necessary to meet market demand. Here, a cross section of biopharma manufacturing executives offer their opinions on what to expect in biopharma manufacturing for 2020 and beyond.
5 Biopharma Finance Experts On What To Expect In 2020 – And Beyond
As politics, finance and biopharma seem forever intertwined, we sought the counsel of five biopharmaceutical industry financial experts toward helping you prepare for what to expect in 2020 – and beyond.
What 9 Biopharma Trendsetters Expect For 2020 – And Beyond
Although AI, machine learning, and quantum computing will someday improve our ability to forecast the future, for now Life Science Leader continues to seek knowledge from a cross section of life sciences industry execs.
What’s The Best Way To Predict The Future?
This year’s annual outlook issue once again features an incredible collection of industry thought leaders. And though some will be fairly familiar, others will be less so.